Toxicity and efficacy of sirolimus: relationship to whole-blood concentrations (Q33332540)

25 July 2017

1 reference

title

Toxicity and efficacy of sirolimus: relationship to whole-blood concentrations (English)

1 reference

25 July 2017

1 reference

Meier-Kriesche HU

1

1 reference

PubMed ID

10823377

25 July 2017

Kaplan B

series ordinal

2

1 reference

25 July 2017

1 January 2000

1 reference

25 July 2017

Clinical Therapeutics

1 reference

25 July 2017

22 Suppl B

1 reference

25 July 2017

B93-100

1 reference

Inhibition of the immune response by rapamycin, a new antifungal antibiotic

25 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989026-8

7 January 2021

Immunosuppressive effects and safety of a sirolimus/cyclosporine combination regimen for renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989026-8

7 January 2021

Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989026-8

7 January 2021

Use of anti-CD25 monoclonal antibody in combination with rapamycin to eliminate cyclosporine treatment during the induction phase of immunosuppression

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989026-8

7 January 2021

Effects of the pharmacokinetic interaction between orally administered sirolimus and cyclosporine on the synergistic prolongation of heart allograft survival in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989026-8

7 January 2021

Sirolimus (rapamycin) potentiates cyclosporine in prevention of acute lung rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989026-8

7 January 2021

Population pharmacokinetics of sirolimus in kidney transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989026-8

7 January 2021

Rapamycin: distribution, pharmacokinetics, and therapeutic range investigations.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989026-8

7 January 2021

Distribution of sirolimus in rat tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989026-8

7 January 2021

Relative tissue distributions of cyclosporine and sirolimus after concomitant peroral administration to the rat: evidence for pharmacokinetic interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989026-8

7 January 2021

The effects of relative timing of sirolimus and cyclosporine microemulsion formulation coadministration on the pharmacokinetics of each agent

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989026-8

7 January 2021

Pharmacokinetics of sirolimus in stable renal transplant patients after multiple oral dose administration

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989026-8

7 January 2021

Prolongation of canine pancreatic islet allograft survival with combined rapamycin and cyclosporine therapy at low doses. Rapamycin efficacy is blood level related

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989026-8

7 January 2021

The relationship of blood concentrations of rapamycin and cyclosporine to suppression of allograft rejection in a rabbit heterotopic heart transplant model

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989026-8

7 January 2021

Comparison of acute rapamycin nephrotoxicity with cyclosporine and FK506.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989026-8

7 January 2021

Synergistic effects of cyclosporine and rapamycin in a chronic nephrotoxicity model

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989026-8

7 January 2021

10.1016/S0149-2918(00)89026-8

Identifiers

DOI

1 reference

25 July 2017

1 reference

PubMed ID

10823377